Impact of direct oral anticoagulant off‐label doses on clinical outcomes of atrial fibrillation patients: a systematic review

J Santos, N António, M Rocha… - British Journal of Clinical …, 2020 - Wiley Online Library
Aims Worldwide observational studies are evidencing discordance between guidelines and
real‐world practice regarding direct oral anticoagulant drug (DOAC) doses. This systematic …

Direct oral anticoagulants: a review of common medication errors

D Barr, QJ Epps - Journal of thrombosis and thrombolysis, 2019 - Springer
Stroke and venous thromboembolism continues to be a major cause of morbidity and
mortality worldwide. The use of anticoagulation therapy has proven effective in the …

Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing

S Moudallel, S Steurbaut, P Cornu… - Frontiers in …, 2018 - frontiersin.org
Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is
required to avoid under-and overdosing that may precipitate strokes or thromboembolic …

Direct oral anticoagulants versus vitamin K antagonists in real-life patients with atrial fibrillation. A systematic review and meta-analysis

C Escobar, J Marti-Almor, AP Cabeza… - Revista Española de …, 2019 - Elsevier
Introduction and objectives To assess the effectiveness of direct oral anticoagulants vs
vitamin K antagonists in real-life patients with atrial fibrillation. Methods A systematic review …

Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses

A Briasoulis, Y Gao, C Inampudi, P Alvarez… - BMC cardiovascular …, 2020 - Springer
Background We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF)
taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and …

[HTML][HTML] Oral anticoagulant use and long-term follow-up results in patients with non-valvular atrial fibrillation in Turkey AFTER-2 study

T Güzel, A Aktan, R Kılıç, B Arslan, B Arık… - Anatolian Journal of …, 2022 - ncbi.nlm.nih.gov
Background: The aim of this study was to investigate the frequency of oral anticoagulant
drugs and time in therapeutic range in patients receiving warfarin in addition to the …

Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta …

A Al Rowily, Z Jalal, MJ Price, MH Abutaleb… - European journal of …, 2021 - Springer
Purpose This study aimed to estimate the prevalence, contributory factors, and severity of
medication errors associated with direct acting oral anticoagulants (DOACs). Methods A …

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain

C Escobar Cervantes, J Marti-Almor, AIP Cabeza… - Plos one, 2022 - journals.plos.org
Aims A Markov model was adapted to assess the real-world cost-effectiveness of
rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral …

Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia

M Giner-Soriano, O Prat-Vallverdú, D Ouchi… - Frontiers in …, 2023 - frontiersin.org
Objectives: To describe the sex and gender differences in the treatment initiation and in the
socio-demographic and clinical characteristics of all patients initiating an oral anticoagulant …

Prevalence of drug‐related problems associated with direct oral anticoagulants in hospitalized patients: a multicenter, cross‐sectional study

M Viprey, R Jeannin, V Piriou… - Journal of clinical …, 2017 - Wiley Online Library
What is known and objective The complex dose regimens of the direct‐acting oral
anticoagulants (DOAC) make their appropriate prescribing highly challenging. Inappropriate …